The National Foundation for Infectious Diseases (NFID) has recently elected eight new members to its Board of Directors. They are:

Malcolm T. Foster, Jr., MD, Chief, Infectious Disease Division at the University of Florida Health Science Center, Jacksonville

Glenda J. Garvey, MD, Professor of Clinical Medicine, Course Director for Third-Year Medical Clerkship, and Acting Chief, Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York

Steven R. Mostow, MD, Chair, Department of Medicine, Co-Director of International Health Pass, Co-Director of the Diagnostic Virus Lab, Rose Medical Center, and Professor of Medicine, University of Colorado School of Medicine, Denver

Barbara E. Murray, MD, Director of the Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical School, Houston

June E. Osborn, MD, Professor of Epidemiology, School of Public Health and Professor of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor

Merle A. Sande, MD, Professor and Chairman, Department of Medicine, University of Utah, Salt Lake City

William Michael Scheld, MD, Professor of Internal Medicine and Neurosurgery, and Associate Chair for Residency Programs, University of Virginia, Charlottesville

Alan D. Tice, MD, Infections Limited, P.S., and Clinical Assistant Professor, University of Washington, Seattle

New NFID Trustees include:

David T. Durack, MB, Dphil, Medical Director Worldwide for Microbiology and Infectious Diseases, Becton Dickinson and Company, and Consulting Professor of Medicine, Duke University Medical Center, Durham

George M. Milne, Jr., PhD, President, Pfizer Inc. Central Research Division and Vice President, Pfizer Inc., Groton, CT

William R. Ringo, President, Infectious Diseases and Generics Business Unit, Eli Lilly and Company, Indianapolis

William W. Robertson, Esq., Partner, Hannoch Weisman, Roseland, NJ